{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T21:03:49Z","timestamp":1789506229667,"version":"build-2803163510"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T00:00:00Z","timestamp":1694736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T00:00:00Z","timestamp":1694736000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Science and Technology Council, Taiwan","award":["MOST 107-2320-B-010-029-MY3"],"award-info":[{"award-number":["MOST 107-2320-B-010-029-MY3"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Rheumatoid arthritis (RA) is characterized by synovial proliferation and lymphocyte accumulation leading to progressive damage of the periarticular bone and the articular cartilage. The hyperplasia of the synovial intima lining mainly consists of fibroblast-like synoviocytes-rheumatoid arthritis (HFLS-RA) which exhibit apoptosis-resistance, hyper-proliferation, and high invasiveness. The therapeutic efficacy of mesenchymal stem cells (MSCs) treatment in RA has been shown to be due to its immuno-regulatory ability. However, the exact factors and mechanisms involved in MSCs treatment in RA remain unclear. In this study, TRAIL receptor-Death receptor 4 (DR4), DR5, and LFA-1 ligand-intercellular adhesion molecule-1 (ICAM-1) were upregulated in IL-1\u03b2-stimulated HFLS-RA. We demonstrated that the total cell number of IL-1\u03b2-stimulated hUCMSCs adhering to IL-1\u03b2-stimulated HFLA-RA increased via LFA-1\/ICAM-1 interaction. Direct co-culture of IL-1\u03b2-stimulated hUCMSCs with IL-1\u03b2-stimulated HFLS-RA increased the apoptosis of HFLS-RA. RA symptoms in the CIA mouse model improved after administration of IL-1\u03b2-stimulated hUCMSCs. In conclusion, IL-1\u03b2-stimulated hUCMSCs adhering to HFLS-RA occurred via LFA-1\/ICAM-1 interaction, apoptosis of HFLS-RA was induced via TRAIL\/DR4, DR5 contact, and RA symptoms and inflammation were significantly improved in a CIA mouse model. The results of this study suggest that IL-1\u03b2-stimulated hUCMSCs have therapeutic potential in RA treatment.<\/jats:p>","DOI":"10.1038\/s41598-023-42585-1","type":"journal-article","created":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T14:02:50Z","timestamp":1694786570000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["IL-1\u03b2 stimulated human umbilical cord mesenchymal stem cells ameliorate rheumatoid arthritis via inducing apoptosis of fibroblast-like synoviocytes"],"prefix":"10.1038","volume":"13","author":[{"given":"Yun-Hsuan","family":"Chiu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Han","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeng-Jong","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hwai-Shi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,15]]},"reference":[{"key":"42585_CR1","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/nature01661","volume":"423","author":"GS Firestein","year":"2003","unstructured":"Firestein, G. S. Evolving concepts of rheumatoid arthritis. Nature 423, 356 (2003).","journal-title":"Nature"},{"key":"42585_CR2","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.0105-2896.2009.00859.x","volume":"233","author":"B Bartok","year":"2010","unstructured":"Bartok, B. & Firestein, G. S. Fibroblast-like synoviocytes: Key effector cells in rheumatoid arthritis. Immunol. Rev. 233, 233\u2013255 (2010).","journal-title":"Immunol. Rev."},{"key":"42585_CR3","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/nrrheum.2012.190","volume":"9","author":"N Bottini","year":"2013","unstructured":"Bottini, N. & Firestein, G. S. Duality of fibroblast-like synoviocytes in RA: Passive responders and imprinted aggressors. Nat. Rev. Rheumatol. 9, 24 (2013).","journal-title":"Nat. Rev. Rheumatol."},{"key":"42585_CR4","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3727\/096368915X688155","volume":"25","author":"J Zhang","year":"2016","unstructured":"Zhang, J. et al. Adipose-derived mesenchymal stem cells (ADSCs) with the potential to ameliorate platelet recovery, enhance megakaryopoiesis, and inhibit apoptosis of bone marrow cells in a mouse model of radiation-induced thrombocytopenia. Cell Transplant. 25, 261\u2013273 (2016).","journal-title":"Cell Transplant."},{"key":"42585_CR5","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.jcyt.2017.12.009","volume":"20","author":"S Shadmanfar","year":"2018","unstructured":"Shadmanfar, S. et al. Intra-articular knee implantation of autologous bone marrow-derived mesenchymal stromal cells in rheumatoid arthritis patients with knee involvement: Results of a randomized, triple-blind, placebo-controlled phase 1\/2 clinical trial. Cytotherapy 20, 499\u2013506 (2018).","journal-title":"Cytotherapy"},{"key":"42585_CR6","doi-asserted-by":"crossref","first-page":"3192","DOI":"10.1089\/scd.2013.0023","volume":"22","author":"L Wang","year":"2013","unstructured":"Wang, L. et al. Human umbilical cord mesenchymal stem cell therapy for patients with active rheumatoid arthritis: Safety and efficacy. Stem Cells Dev. 22, 3192\u20133202 (2013).","journal-title":"Stem Cells Dev."},{"key":"42585_CR7","volume":"12","author":"Y Liu","year":"2010","unstructured":"Liu, Y. et al. Therapeutic potential of human umbilical cord mesenchymal stem cells in the treatment of rheumatoid arthritis. Arthritis Res. Ther. 12, R210 (2010).","journal-title":"Arthritis Res. Ther."},{"key":"42585_CR8","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.cellimm.2012.06.010","volume":"278","author":"S Liu","year":"2012","unstructured":"Liu, S. et al. Immune characterization of mesenchymal stem cells in human umbilical cord Wharton\u2019s jelly and derived cartilage cells. Cell. Immunol. 278, 35\u201344 (2012).","journal-title":"Cell. Immunol."},{"key":"42585_CR9","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.molmed.2010.02.005","volume":"16","author":"J Ankrum","year":"2010","unstructured":"Ankrum, J. & Karp, J. M. Mesenchymal stem cell therapy: Two steps forward, one step back. Trends Mol. Med. 16, 203\u2013209 (2010).","journal-title":"Trends Mol. Med."},{"key":"42585_CR10","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1146\/annurev-bioeng-070909-105309","volume":"12","author":"B Parekkadan","year":"2010","unstructured":"Parekkadan, B. & Milwid, J. M. Mesenchymal stem cells as therapeutics. Annu. Rev. Biomed. Eng. 12, 87\u2013117 (2010).","journal-title":"Annu. Rev. Biomed. Eng."},{"key":"42585_CR11","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S1474-4422(11)70121-1","volume":"10","author":"A Uccelli","year":"2011","unstructured":"Uccelli, A., Laroni, A. & Freedman, M. S. Mesenchymal stem cells for the treatment of multiple sclerosis and other neurological diseases. Lancet Neurol. 10, 649\u2013656 (2011).","journal-title":"Lancet Neurol."},{"key":"42585_CR12","doi-asserted-by":"crossref","first-page":"4779","DOI":"10.3748\/wjg.v21.i16.4779","volume":"21","author":"R Chinnadurai","year":"2015","unstructured":"Chinnadurai, R., Ng, S., Velu, V. & Galipeau, J. Challenges in animal modelling of mesenchymal stromal cell therapy for inflammatory bowel disease. World J. Gastroenterol. WJG 21, 4779 (2015).","journal-title":"World J. Gastroenterol. WJG"},{"key":"42585_CR13","volume":"2015","author":"S Lee","year":"2015","unstructured":"Lee, S., Choi, E., Cha, M.-J. & Hwang, K.-C. Cell adhesion and long-term survival of transplanted mesenchymal stem cells: A prerequisite for cell therapy. Oxid. Med. Cell. Longev. 2015, 632902 (2015).","journal-title":"Oxid. Med. Cell. Longev."},{"key":"42585_CR14","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.yjmcc.2008.01.004","volume":"45","author":"E Chavakis","year":"2008","unstructured":"Chavakis, E., Urbich, C. & Dimmeler, S. Homing and engraftment of progenitor cells: A prerequisite for cell therapy. J. Mol. Cell. Cardiol. 45, 514\u2013522 (2008).","journal-title":"J. Mol. Cell. Cardiol."},{"key":"42585_CR15","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.3727\/096368914X685258","volume":"24","author":"C-Y Lin","year":"2015","unstructured":"Lin, C.-Y. et al. IL-1\u03b2-induced mesenchymal stem cell migration involves MLCK activation via PKC signaling. Cell Transplant. 24, 2011\u20132028 (2015).","journal-title":"Cell Transplant."},{"key":"42585_CR16","volume":"2018","author":"M-S Chen","year":"2018","unstructured":"Chen, M.-S. et al. IL-1\u03b2-induced matrix metalloprotease-1 promotes mesenchymal stem cell migration via PAR1 and G-protein-coupled signaling pathway. Stem Cells Int. 2018, 3524759 (2018).","journal-title":"Stem Cells Int."},{"key":"42585_CR17","volume":"16","author":"C-H Chang","year":"2021","unstructured":"Chang, C.-H. et al. Interleukin-1\u03b2-induced matrix metalloproteinase-3 via ERK1\/2 pathway to promote mesenchymal stem cell migration. PLoS\u00a0One 16, e0252163 (2021).","journal-title":"PLoS\u00a0One"},{"key":"42585_CR18","volume":"2019","author":"T-Y Wu","year":"2019","unstructured":"Wu, T.-Y., Liang, Y.-H., Wu, J.-C. & Wang, H.-S. Interleukin-1\u03b2 enhances umbilical cord mesenchymal stem cell adhesion ability on human umbilical vein endothelial cells via LFA-1\/ICAM-1 interaction. Stem Cells Int. 2019, 7267142 (2019).","journal-title":"Stem Cells Int."},{"key":"42585_CR19","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1186\/s13287-018-1032-9","volume":"9","author":"Y-C Guo","year":"2018","unstructured":"Guo, Y.-C., Chiu, Y.-H., Chen, C.-P. & Wang, H.-S. Interleukin-1\u03b2 induces CXCR3-mediated chemotaxis to promote umbilical cord mesenchymal stem cell transendothelial migration. Stem Cell Res. Ther. 9, 281 (2018).","journal-title":"Stem Cell Res. Ther."},{"key":"42585_CR20","doi-asserted-by":"crossref","first-page":"10277","DOI":"10.1073\/pnas.92.22.10277","volume":"92","author":"A Qu","year":"1995","unstructured":"Qu, A. & Leahy, D. J. Crystal structure of the I-domain from the CD11a\/CD18 (LFA-1, alpha L beta 2) integrin. Proc. Natl. Acad. Sci. 92, 10277\u201310281 (1995).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"42585_CR21","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1146\/annurev.immunol.25.022106.141618","volume":"25","author":"B-H Luo","year":"2007","unstructured":"Luo, B.-H., Carman, C. V. & Springer, T. A. Structural basis of integrin regulation and signaling. Annu. Rev. Immunol. 25, 619\u2013647 (2007).","journal-title":"Annu. Rev. Immunol."},{"key":"42585_CR22","doi-asserted-by":"crossref","first-page":"3283","DOI":"10.1182\/blood.V97.10.3283","volume":"97","author":"O Kollet","year":"2001","unstructured":"Kollet, O. et al. Rapid and efficient homing of human CD34+CD38\u2212\/lowCXCR4+ stem and progenitor cells to the bone marrow and spleen of NOD\/SCID and NOD\/SCID\/B2m null mice. Blood 97, 3283\u20133291 (2001).","journal-title":"Blood"},{"key":"42585_CR23","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1182\/blood-2005-04-1417","volume":"106","author":"T Lapidot","year":"2005","unstructured":"Lapidot, T., Dar, A. & Kollet, O. How do stem cells find their way home?. Blood 106, 1901\u20131910 (2005).","journal-title":"Blood"},{"key":"42585_CR24","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1084\/jem.175.1.185","volume":"175","author":"AR de Fougerolles","year":"1992","unstructured":"de Fougerolles, A. R. & Springer, T. A. Intercellular adhesion molecule 3, a third adhesion counter-receptor for lymphocyte function-associated molecule 1 on resting lymphocytes. J. Exp. Med. 175, 185\u2013190 (1992).","journal-title":"J. Exp. Med."},{"key":"42585_CR25","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1002\/jlb.66.6.876","volume":"66","author":"KA Roebuck","year":"1999","unstructured":"Roebuck, K. A. & Finnegan, A. Regulation of intercellular adhesion molecule-1 (CD54) gene expression. J. Leukoc. Biol. 66, 876\u2013888 (1999).","journal-title":"J. Leukoc. Biol."},{"key":"42585_CR26","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1172\/JCI116975","volume":"93","author":"MJ Elices","year":"1994","unstructured":"Elices, M. J. et al. Expression and functional significance of alternatively spliced CS1 fibronectin in rheumatoid arthritis microvasculature. J. Clin. Investig. 93, 405\u2013416 (1994).","journal-title":"J. Clin. Investig."},{"key":"42585_CR27","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1002\/art.1780391103","volume":"39","author":"GS Firestein","year":"1996","unstructured":"Firestein, G. S. Invasive fibroblast-like synoviocytes in rheumatoid arthritis. Passive responders or transformed aggressors?. Arthritis Rheum. 39, 1781\u20131790 (1996).","journal-title":"Arthritis Rheum."},{"key":"42585_CR28","doi-asserted-by":"crossref","first-page":"R129","DOI":"10.1186\/ar3067","volume":"12","author":"CK Wong","year":"2010","unstructured":"Wong, C. K. et al. Effects of inflammatory cytokine IL-27 on the activation of fibroblast-like synoviocytes in rheumatoid arthritis. Arthritis Res. Ther. 12, R129 (2010).","journal-title":"Arthritis Res. Ther."},{"key":"42585_CR29","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1172\/JCI6926","volume":"104","author":"A Ashkenazi","year":"1999","unstructured":"Ashkenazi, A. et al. Safety and antitumor activity of recombinant soluble Apo2 ligand. J. Clin. Investig. 104, 155\u2013162 (1999).","journal-title":"J. Clin. Investig."},{"key":"42585_CR30","doi-asserted-by":"crossref","first-page":"23319","DOI":"10.1074\/jbc.M910438199","volume":"275","author":"A Truneh","year":"2000","unstructured":"Truneh, A. et al. Temperature-sensitive differential affinity of TRAIL for its receptors: DR5 is the highest affinity receptor. J. Biol. Chem. 275, 23319\u201323325 (2000).","journal-title":"J. Biol. Chem."},{"key":"42585_CR31","doi-asserted-by":"crossref","first-page":"8628","DOI":"10.1038\/sj.onc.1207232","volume":"22","author":"S Wang","year":"2003","unstructured":"Wang, S. & El-Deiry, W. S. TRAIL and apoptosis induction by TNF-family death receptors. Oncogene 22, 8628 (2003).","journal-title":"Oncogene"},{"key":"42585_CR32","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/sj.cr.7290236","volume":"14","author":"FC Kimberley","year":"2004","unstructured":"Kimberley, F. C. & Screaton, G. R. Following a TRAIL: Update on a ligand and its five receptors. Cell Res. 14, 359 (2004).","journal-title":"Cell Res."},{"key":"42585_CR33","doi-asserted-by":"crossref","first-page":"15709","DOI":"10.1074\/jbc.M414469200","volume":"280","author":"J Morel","year":"2005","unstructured":"Morel, J., Audo, R., Hahne, M. & Combe, B. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) induces rheumatoid arthritis synovial fibroblast proliferation through mitogen-activated protein kinases and phosphatidylinositol 3-kinase\/Akt. J. Biol. Chem. 280, 15709\u201315718 (2005).","journal-title":"J. Biol. Chem."},{"key":"42585_CR34","first-page":"31","volume":"299","author":"SK Kelley","year":"2001","unstructured":"Kelley, S. K. et al. Preclinical studies to predict the disposition of Apo2L\/tumor necrosis factor-related apoptosis-inducing ligand in humans: Characterization of in vivo efficacy, pharmacokinetics, and safety. J. Pharmacol. Exp. Ther. 299, 31\u201338 (2001).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"42585_CR35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-020-79139-8","volume":"11","author":"Y-H Liang","year":"2021","unstructured":"Liang, Y.-H., Wu, J.-M., Teng, J.-W., Hung, E. & Wang, H.-S. Embelin downregulated cFLIP in breast cancer cell lines facilitate anti-tumor effect of IL-1\u03b2-stimulated human umbilical cord mesenchymal stem cells. Sci. Rep. 11, 1\u201313 (2021).","journal-title":"Sci. Rep."},{"key":"42585_CR36","doi-asserted-by":"crossref","unstructured":"Fulda, S. & Debatin, K.-M. Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy. Oncogene 25, 4798\u20134811 (2006).","DOI":"10.1038\/sj.onc.1209608"},{"key":"42585_CR37","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/jbt.21774","volume":"30","author":"Y Zhang","year":"2016","unstructured":"Zhang, Y. & Zhang, B. Trichostatin A, an inhibitor of histone deacetylase, inhibits the viability and invasiveness of hypoxic rheumatoid arthritis fibroblast-like synoviocytes via PI3K\/Akt signaling. J. Biochem. Mol. Toxicol. 30, 163\u2013169 (2016).","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"42585_CR38","doi-asserted-by":"crossref","first-page":"3866","DOI":"10.1002\/art.20615","volume":"50","author":"R Garc\u00eda-Vicu\u00f1a","year":"2004","unstructured":"Garc\u00eda-Vicu\u00f1a, R. et al. CC and CXC chemokine receptors mediate migration, proliferation, and matrix metalloproteinase production by fibroblast-like synoviocytes from rheumatoid arthritis patients. Arthritis Rheum. 50, 3866\u20133877 (2004).","journal-title":"Arthritis Rheum."},{"key":"42585_CR39","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/j.1365-2249.2004.02534.x","volume":"137","author":"T Miyashita","year":"2004","unstructured":"Miyashita, T. et al. Osteoprotegerin (OPG) acts as an endogenous decoy receptor in tumour necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis of fibroblast-like synovial cells. Clin. Exp. Immunol. 137, 430\u2013436 (2004).","journal-title":"Clin. Exp. Immunol."},{"key":"42585_CR40","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1093\/qjmed\/hcu033","volume":"107","author":"J El-Jawhari","year":"2014","unstructured":"El-Jawhari, J., El-Sherbiny, Y., Jones, E. & McGonagle, D. Mesenchymal stem cells, autoimmunity and rheumatoid arthritis. QJM 107, 505\u2013514 (2014).","journal-title":"QJM"},{"key":"42585_CR41","volume":"2015","author":"C Zhao","year":"2015","unstructured":"Zhao, C. et al. Umbilical cord-derived mesenchymal stem cells inhibit cadherin-11 expression by fibroblast-like synoviocytes in rheumatoid arthritis. J. Immunol. Res. 2015, 137695 (2015).","journal-title":"J. Immunol. Res."},{"key":"42585_CR42","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.4049\/jimmunol.172.4.2668","volume":"172","author":"MA Olman","year":"2004","unstructured":"Olman, M. A. et al. Pulmonary edema fluid from patients with early lung injury stimulates fibroblast proliferation through IL-1\u03b2-induced IL-6 expression. J. Immunol. 172, 2668\u20132677 (2004).","journal-title":"J. Immunol."},{"key":"42585_CR43","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/jcp.21770","volume":"220","author":"A Schwarznau","year":"2009","unstructured":"Schwarznau, A. et al. IL-1\u03b2 receptor blockade protects islets against pro-inflammatory cytokine induced necrosis and apoptosis. J. Cell. Physiol. 220, 341\u2013347 (2009).","journal-title":"J. Cell. Physiol."},{"key":"42585_CR44","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/imm.12167","volume":"141","author":"M Schenk","year":"2014","unstructured":"Schenk, M. et al. Interleukin-1\u03b2 triggers the differentiation of macrophages with enhanced capacity to present mycobacterial antigen to T cells. Immunology 141, 174\u2013180 (2014).","journal-title":"Immunology"},{"key":"42585_CR45","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1007\/s12015-012-9364-9","volume":"8","author":"R Carrero","year":"2012","unstructured":"Carrero, R. et al. IL1\u03b2 induces mesenchymal stem cells migration and leucocyte chemotaxis through NF-\u03baB. Stem Cell Rev. Rep. 8, 905\u2013916 (2012).","journal-title":"Stem Cell Rev. Rep."},{"key":"42585_CR46","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/art.1780380202","volume":"38","author":"WP Arend","year":"1995","unstructured":"Arend, W. P. & Dayer, J.-M. Inhibition of the production and effects of interleukin-1 and tumor necrosis factor alpha in rheumatoid arthritis. Arthritis Rheum. 38, 151\u2013160 (1995).","journal-title":"Arthritis Rheum."},{"key":"42585_CR47","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1097\/00002281-199705000-00010","volume":"9","author":"G Panayi","year":"1997","unstructured":"Panayi, G. T-cell-dependent pathways in rheumatoid arthritis. Curr. Opin. Rheumatol. 9, 236\u2013240 (1997).","journal-title":"Curr. Opin. Rheumatol."},{"key":"42585_CR48","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1172\/JCI112350","volume":"77","author":"J-M Dayer","year":"1986","unstructured":"Dayer, J.-M., de Rochemonteix, B., Burrus, B., Demczuk, S. & Dinarello, C. A. Human recombinant interleukin 1 stimulates collagenase and prostaglandin E2 production by human synovial cells. J. Clin. Investig. 77, 645\u2013648 (1986).","journal-title":"J. Clin. Investig."},{"key":"42585_CR49","doi-asserted-by":"crossref","first-page":"iii2","DOI":"10.1093\/rheumatology\/keg439","volume":"43","author":"J Kay","year":"2004","unstructured":"Kay, J. & Calabrese, L. The role of interleukin-1 in the pathogenesis of rheumatoid arthritis. Rheumatology 43, iii2\u2013iii9 (2004).","journal-title":"Rheumatology"},{"key":"42585_CR50","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/nrc776","volume":"2","author":"FH Igney","year":"2002","unstructured":"Igney, F. H. & Krammer, P. H. Death and anti-death: Tumour resistance to apoptosis. Nat. Rev. Cancer 2, 277 (2002).","journal-title":"Nat. Rev. Cancer"},{"key":"42585_CR51","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S1359-6101(03)00029-7","volume":"14","author":"A Almasan","year":"2003","unstructured":"Almasan, A. & Ashkenazi, A. Apo2L\/TRAIL: Apoptosis signaling, biology, and potential for cancer therapy. Cytokine Growth Factor Rev. 14, 337\u2013348 (2003).","journal-title":"Cytokine Growth Factor Rev."},{"key":"42585_CR52","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1038\/cdd.2009.38","volume":"16","author":"R Audo","year":"2009","unstructured":"Audo, R., Combe, B., Coulet, B., Morel, J. & Hahne, M. The pleiotropic effect of TRAIL on tumor-like synovial fibroblasts from rheumatoid arthritis patients is mediated by caspases. Cell Death Differ. 16, 1227 (2009).","journal-title":"Cell Death Differ."},{"key":"42585_CR53","volume":"7","author":"T-H Shin","year":"2016","unstructured":"Shin, T.-H. et al. Human umbilical cord blood-stem cells direct macrophage polarization and block inflammasome activation to alleviate rheumatoid arthritis. Cell Death Dis. 7, e2524 (2016).","journal-title":"Cell Death Dis."},{"key":"42585_CR54","doi-asserted-by":"crossref","first-page":"7463","DOI":"10.3892\/mmr.2015.4394","volume":"12","author":"J Gu","year":"2015","unstructured":"Gu, J. et al. Human umbilical cord mesenchymal stem cells improve the immune-associated inflammatory and prothrombotic state in collagen type-II-induced arthritic rats. Mol. Med. Rep. 12, 7463\u20137470 (2015).","journal-title":"Mol. Med. Rep."},{"key":"42585_CR55","unstructured":"Ying-Xuan Zeng, H.-S. W. The effects of IL-1\u03b2 stimulated human umbilical cord mesenchymal stem cells on polarization and apoptosis of macrophages in rheumatoid arthritis. Master Thesis (2022)."},{"key":"42585_CR56","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1007\/s10439-020-02487-z","volume":"48","author":"P Wuttisarnwattana","year":"2020","unstructured":"Wuttisarnwattana, P. et al. Cryo-imaging of stem cell biodistribution in mouse model of graft-versus-host-disease. Ann. Biomed. Eng. 48, 1702\u20131711 (2020).","journal-title":"Ann. Biomed. Eng."},{"key":"42585_CR57","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1111\/liv.12962","volume":"36","author":"WP Tang","year":"2016","unstructured":"Tang, W. P. et al. Splenectomy enhances the therapeutic effect of adipose tissue-derived mesenchymal stem cell infusion on cirrhosis rats. Liver Int. 36, 1151\u20131159 (2016).","journal-title":"Liver Int."},{"key":"42585_CR58","volume":"2016","author":"J Cao","year":"2016","unstructured":"Cao, J. et al. In vivo tracking of systemically administered allogeneic bone marrow mesenchymal stem cells in normal rats through bioluminescence imaging. Stem Cells Int. 2016, 3970942 (2016).","journal-title":"Stem Cells Int."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-42585-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-42585-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-42585-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T09:15:41Z","timestamp":1700298941000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-42585-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,15]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["42585"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-42585-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2666186\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,15]]},"assertion":[{"value":"7 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"H.-S. Wang and J.-J. Hwang declare that a patent entitled \u201cComposition and Use of Interleukin Stimulated Human Umbilical Cord Mesenchymal Stem Cells for the Treatment of Rheumatoid Arthritis\u201d granted in Taiwan on 26-July-2022 (no. I 782355) is based on the research in this paper. An US patent application of the same title was filed on 8-JUN-2021. National Yang Ming Chiao Tung University holds awarded and pending patents. All other authors declare they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"15344"}}